当前位置:首页 - 行情中心 - 古汉医药(000590) - 财务分析 - 现金流量表

古汉医药

(000590)

  

流通市值:19.15亿  总市值:19.16亿
流通股本:2.39亿   总股本:2.39亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金125,812,986.9759,106,922.59383,741,332.37258,105,478.45
  收到的税费返还--556,885.95-
  收到其他与经营活动有关的现金8,140,666.962,554,076.4618,946,102.0371,494,153.95
  经营活动现金流入小计133,953,653.9361,660,999.05403,244,320.35329,599,632.4
  购买商品、接受劳务支付的现金51,707,156.4223,433,262.75146,016,342.88112,486,788.09
  支付给职工以及为职工支付的现金72,582,001.6745,567,563.22133,398,738.88105,089,944.64
  支付的各项税费16,513,017.697,531,911.0746,870,044.3335,904,790.92
  支付其他与经营活动有关的现金15,344,424.878,969,182.5848,001,972.2342,986,380.86
  经营活动现金流出小计156,146,600.6585,501,919.62374,287,098.32296,467,904.51
  经营活动产生的现金流量净额-22,192,946.72-23,840,920.5728,957,222.0333,131,727.89
二、投资活动产生的现金流量:
  收回投资收到的现金68,000,000-254,000,000168,000,000
  取得投资收益收到的现金281,334.5235,881.64556,188.87355,929.69
  处置固定资产、无形资产和其他长期资产收回的现金净额2,342,2002,341,700126,069126,069
  收到的其他与投资活动有关的现金252,336.98252,336.9859,747,663.01-
  投资活动现金流入小计70,875,871.52,629,918.62314,429,920.88168,481,998.69
  购建固定资产、无形资产和其他长期资产支付的现金20,558,268.099,677,260.6848,807,066.0232,333,049.45
  投资支付的现金103,000,00043,000,000254,000,000201,000,000
  支付其他与投资活动有关的现金406,848.17---
  投资活动现金流出小计123,965,116.2652,677,260.68302,807,066.02233,333,049.45
  投资活动产生的现金流量净额-53,089,244.76-50,047,342.0611,622,854.86-64,851,050.76
三、筹资活动产生的现金流量:
  取得借款收到的现金8,335,965.85-48,680,830.3646,899,788.77
  收到其他与筹资活动有关的现金--6,000,0005,000,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计8,335,965.85-54,680,830.3651,899,788.77
  偿还债务支付的现金10,000,000-71,904,801.2835,000,000
  分配股利、利润或偿付利息支付的现金1,221,101.37743,351.373,780,155.722,848,669.91
  其中:子公司支付给少数股东的股利、利润269,684.7269,684.7427,471.63317,471.63
  支付其他与筹资活动有关的现金1,344,134.62641,937.2410,164,214.661,922,618.04
  筹资活动现金流出小计12,565,235.991,385,288.6185,849,171.6639,771,287.95
  筹资活动产生的现金流量净额-4,229,270.14-1,385,288.61-31,168,341.312,128,500.82
五、现金及现金等价物净增加额-79,511,461.62-75,273,551.249,411,735.59-19,590,822.05
  加:期初现金及现金等价物余额170,000,423.34170,377,818.18160,588,687.75160,588,687.75
  期末现金及现金等价物余额90,488,961.7295,104,266.94170,000,423.34140,997,865.7
补充资料:
  净利润-14,976,930.24--50,074,553.84-
  资产减值准备866,240.23-32,796,563.86-
  固定资产和投资性房地产折旧11,879,809.45-22,733,192.81-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,879,809.45-22,733,192.81-
  无形资产摊销2,906,047.38-6,616,198.82-
  长期待摊费用摊销1,439,221.46-1,666,086.17-
  处置固定资产、无形资产和其他长期资产的损失-312,945.83--2,422,610.35-
  固定资产报废损失883.24-17,700.82-
  财务费用920,360.96-3,388,277.13-
  投资损失-760,003.51--778,142.82-
  递延所得税-829,430.47--6,060,201.94-
  其中:递延所得税资产减少-322,029.13--6,720,606.07-
    递延所得税负债增加-507,401.34-660,404.13-
  存货的减少-12,729,830.85-14,460,673.19-
  经营性应收项目的减少2,568,963.39-38,524,925.12-
  经营性应付项目的增加-14,125,611.75--34,317,599.45-
  其他140,140.14--377,394.84-
  现金的期末余额90,488,961.72-170,000,423.34-
  减:现金的期初余额170,000,423.34-160,588,687.75-
  现金及现金等价物的净增加额-79,511,461.62-9,411,735.59-
公告日期2026-08-272026-04-282026-03-312025-10-30
审计意见(境内)标准无保留意见
TOP↑